People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Halia Therapeutics, Inc. | — | Biotechnology | Series A | $23.9M | $1.1M | 2025 |
Gary B. Sabin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gary B. Sabin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Bearss | 1 | 5 |
| Jim B. Savas | 1 | 1 |
| Jeffrey Burton | 1 | 1 |
| Todd S.K. Pedersen | 1 | 1 |
| Jared Bearss | 1 | 1 |
| John S.K. Kauwe | 1 | 1 |
| Jim S.K. Savas | 1 | 1 |
| MIKE S.K. MCCULLAR | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.